ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2039

Assessing Barriers to Uveitis Screening in Patients with JIA: A Qualitative Study

Laura Ballenger1, Kyla Driest2 and Stacy P. Ardoin3, 1Nationwide Children's Hospital, Columbus, OH, 2Rheumatology, Nationwide Children's Hospital, Columbus, OH, 3Pediatric & Adult Rheumatology, Ohio State University, Columbus, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Compliance, juvenile idiopathic arthritis (JIA), quality improvement and uveitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Quality Measures and Quality of Care I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Uveitis is a major complication in patients with juvenile idiopathic arthritis (JIA) can be completely asymptomatic until vision loss develops. In order to prevent ocular complications, it is important to adhere to the recommended screening guidelines which range from every 3 to 12 months depending on JIA subtype, age of onset, duration of diagnosis and ANA status. However, this schedule may be difficulty for patients to adhere to. Little literature exists regarding compliance with uveitis screening in patients with JIA and we do not fully understand the barriers to obtaining screening eye exams. The specific aim of this quality improvement study as to assess barriers to obtaining screening eye exams in patients with JIA.

Methods: Patients with JIA were identified by ICD-9 code in our electronic medical record (EMR) prior to scheduled follow up appointments. They were then identified a adherent or non-adherent with established uveitis screening guidelines based on documentation of eye exams in the EMR. The guardians of those patients that were non-adherent were called the week prior to their scheduled appointments and a semi-structured interview was conducted. The interview included questions regarding the patient’s most recent eye exam, knowledge about the screening frequency, and barriers to completing the eye exams. The results were then analyzed qualitatively to determine any categorical variables present and the relative importance of each variable.

Results: 92 patients, ages 3-22 years, were identified as non-adherent to screening exam guidelines out of a possible 246 total patients with JIA with upcoming appointments. 45 guardians of these patients or patients older than 18 years were interviewed by phone. Responses were categorized into system problems, access to care,and knowledge. System problems (57.8%) represented the largest category. These problems included the most recent eye exam not being in the EMR, the wrong provider was identified in the EMR, or difficulty with scheduling an appointment. 48.9% of patients who were identified by review of EMR record as non-adherent with screening exams had parent/guardian reports of more recent eye exams. Lack of appropriate parent knowledge regarding uveitis screening was also identified as a key barrier with 26.7% unaware of how often screening exams should be performed. Access to care was the least cited category with 20% of those interviewed identifying a barrier such as transportation or insurance.

Conclusion: This qualitative study identified system problems as the greatest barrier to obtaining screening eye exams in this patient population. The most common system problem was the most recent eye exam not being in the EMR. Lack of knowledge also appears to contribute. These results will be helpful in planning the next steps in improving compliance with uveitis screening.


Disclosure: L. Ballenger, None; K. Driest, None; S. P. Ardoin, None.

To cite this abstract in AMA style:

Ballenger L, Driest K, Ardoin SP. Assessing Barriers to Uveitis Screening in Patients with JIA: A Qualitative Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/assessing-barriers-to-uveitis-screening-in-patients-with-jia-a-qualitative-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-barriers-to-uveitis-screening-in-patients-with-jia-a-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology